Omapatrilat Reduces Pulse Pressure and Proximal Aortic Stiffness in Patients with Systolic Hypertension. Results of the Conduit Hemodynamics of Omipatrilat International Research Study - Omapatrilat


The goal of this study was to assess the safety and efficacy of omapatrilat, a vasopeptidase with both ACE and neutral endopeptidase inhibitor activity, on vascular stiffness in patients with predominantly systolic hypertension.